Expression of a Truncated Epidermal Growth Factor Receptor-like Protein (TEGFR) in Ovarian Cancer

By Ilekis J.V.   Gariti J.   Niederberger C.   Scoccia B.  

Gynecologic Oncology, Vol. 65, Iss. 1, 1997-04 ,pp. : 36-41

Elsevier

Access to resources Recommend Favorite

Cyclooxygenase-2 (COX-2), Epidermal Growth Factor Receptor (EGFR), and Her-2/neu Expression in Ovarian Cancer

By Ferrandina G.   Ranelletti F.O.   Lauriola L.   Fanfani F.   Legge F.   Mottolese M.   Nicotra M.R.   Natali P.G.   Zakut V.H.   Scambia G.  

Gynecologic Oncology, Vol. 85, Iss. 2, 2002-05 ,pp. : 305-310

Academic Press

Access to resources Recommend Favorite

Clinical significance of heparin-binding epidermal growth factor-like growth factor and a disintegrin and metalloprotease 17 expression in human ovarian cancer

By Vogiatzi Paraskevi  

The Women's Oncology Review, Vol. 5, Iss. 3, 2005-09 ,pp. : 145-147

Informa Healthcare

Access to resources Recommend Favorite

Correlation of the expression of vascular endothelial growth factor and its receptors with microvessel density in ovarian cancer

By        

Oncology Letters, Vol. 6, Iss. 1, 2013-01 ,pp. : 175-180

Spandidos Publications

Access to resources Recommend Favorite

Immunohistochemical expression of epidermal growth factor receptor in breast cancer

By Nozoe Tadahiro  

Breast Cancer, Vol. 18, Iss. 1, 2011-01 ,pp. : 37-41

Springer Publishing Company

Access to resources Recommend Favorite